Currencies / RXRX
RXRX: Recursion Pharmaceuticals Inc - Class A
4.93
USD
0.22
(4.27%)
RXRX exchange rate has changed by -4.27% for today. During the day, the instrument was traded at a low of 4.80 and at a high of 5.22.
Follow Recursion Pharmaceuticals Inc - Class A dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
RXRX News
- Investing MS initiates coverage on AI Biotechs, flags key pipeline catalysts
- Investing Recursion Pharmaceuticals stock coverage resumed at Morgan Stanley
- Investing Recursion Pharmaceuticals stockholders elect three Class I directors
- Investing Recursion Pharmaceuticals price target lowered to $5 by Morgan Stanley
- The Motley Fool Is This Beaten-Down Cathie Wood Artificial Intelligence (AI) Stock a Buy?
- Investing Recursion Q1 2025 slides: AI platform advances pipeline amid earnings miss
- Seeking Alpha Recursion: Lack Of Near-Term Catalysts Leaves The Stock Vulnerable (NASDAQ:RXRX)
- The Motley Fool Why Recursion Pharmaceuticals Was Bouncing Higher on Tuesday
- Benzinga Recursion Pharmaceuticals Stock Is Up 10% Today: What's Happening? - Recursion Pharmaceuticals (NASDAQ:RXRX)
- Benzinga Applied Digital And Riot Platforms Are Among Top 10 Mid-Cap Gainers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio? - Applied Digital (NASDAQ:APLD), Riot Platforms (NASDAQ:RIOT)
- Benzinga Recursion Pharmaceuticals Stock Surges On Breakthrough AI Model Launch With MIT - Recursion Pharmaceuticals (NASDAQ:RXRX)
- Investing Recursion Pharmaceuticals shares surge on AI model release
- Investing Boltz-2 AI model sets new speed benchmark in drug discovery
- Investing What’s the role of generative AI in drug discovery?
- Investing Recursion to Participate in Upcoming Investor Conferences
- TheStreet Analyst resets Nvidia-backed AI stock price target after 200% surge
- The Motley Fool 3 Monster Stocks to Hold for the Next 10 Years
- TheStreet Analysts double price target of new AI stock backed by Nvidia
- GuruFocus Tempus AI Gets Bullish Boost from BTIG on Data Strength, Expansion Moves
- TipRanks BTIG Analyst Sees Tempus AI (TEM) as “Significant Free Call Option” with 48% Upside - TipRanks.com
- The Motley Fool This Beaten-Down Artificial Intelligence (AI) Stock Just Got Some Great News: Time to Buy?
- Benzinga Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing - Absci (NASDAQ:ABSI), Charles River (NYSE:CRL)
- Benzinga These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio? - AeroVironment (NASDAQ:AVAV), Recursion Pharmaceuticals (NASDAQ:RXRX)
- Seeking Alpha Recursion (RXRX): FDA To Replace Animal Testing With AI? - A Small But Necessary Win
Daily Range
4.80
5.22
Year Range
3.79
12.36
- Previous Close
- 5.27
- Open
- 5.15
- Bid
- 4.93
- Ask
- 5.23
- Low
- 4.80
- High
- 5.22
- Volume
- 27.899 K
- Daily Change
- -4.27%
- Month Change
- -1.40%
- 6 Months Change
- -28.96%
- Year Change
- -39.73%
08 July, Tuesday
15:30
USD
- Act
- Fcst
- Prev
- 3.940%
16:00
USD
- Act
- Fcst
- Prev
16:00
USD
- Act
- Fcst
- 102.8
- Prev
- 98.8
17:00
USD
- Act
- Fcst
- Prev
- 3.972%
19:00
USD
- Act
- Fcst
- $13.27 B
- Prev
- $17.87 B